CMS offers clarification related to grievance investigation timelines

By Jon Jordan
Fri, Oct, 23, 2015

Hepatitis C medications have likely impacted your 2015 budget. They are poised to potentially impact future year's budgets and may break your budget if you are not aware of how this category is impacting prescription...

Latest

Don’t overlook CMS’ 2015 program audit modifications

Chris Hanson-Ehlinger
Wed, Apr, 01, 2015

Odds are high your plan faces a CMS program audit in 2015

Chris Hanson-Ehlinger
Thu, Mar, 26, 2015

Receive full value from your PBM rebates

Chris Hanson-Ehlinger
Thu, Nov, 20, 2014

Complex 2014 Determinations reporting section challenges plans

Chris Hanson-Ehlinger
Wed, Sep, 24, 2014

Poor scores posted for 2013 data validation SNP reporting

Chris Hanson-Ehlinger
Thu, Sep, 11, 2014

Align data validation stakeholders to avoid last minute mistakes

Chris Hanson-Ehlinger
Mon, Aug, 18, 2014

Complex CMS changes may cut into your data validation score

Chris Hanson-Ehlinger
Thu, Jul, 24, 2014

Are your PBM pricing discounts seriously underperforming?

Chris Hanson-Ehlinger
Mon, Apr, 07, 2014

No change to CMS Cycle 2014 SNP reporting requirements

Chris Hanson-Ehlinger
Thu, Jan, 23, 2014

Three ways to improve Standard 3 data reporting accuracy

Chris Hanson-Ehlinger
Wed, Oct, 23, 2013

Four CMS standards that definitely require P&Ps

Chris Hanson-Ehlinger
Wed, Oct, 23, 2013

Are you on top of Department of Labor SBC requirements?

Chris Hanson-Ehlinger
Thu, Oct, 03, 2013

PBM contract clarity defines prescription drug plan success

Chris Hanson-Ehlinger
Wed, Aug, 21, 2013

How fraud, waste and abuse hurt your prescription drug plan

Chris Hanson-Ehlinger
Mon, Aug, 19, 2013

HRSA increases 340B scrutiny

Chris Hanson-Ehlinger
Tue, Jul, 30, 2013

Need guidance on how CMS determines CDE requests?

Chris Hanson-Ehlinger
Mon, Jul, 29, 2013

Are you correctly categorizing data validation audit grievances?

Chris Hanson-Ehlinger
Sun, Jul, 28, 2013

Is there a trend toward “commodification” in pharmacy?

Chris Hanson-Ehlinger
Fri, Jul, 26, 2013

CMS MTM changes impact 2014 reporting

Chris Hanson-Ehlinger
Mon, Jul, 01, 2013

CMS Recent Changes – Part C Grievances

Chris Hanson-Ehlinger
Fri, Jun, 21, 2013

CMS Changes: Organization Determinations/Reconsiderations (ODR)

Chris Hanson-Ehlinger
Fri, Jun, 14, 2013

Medicare Part C Changes – Serious Reportable Adverse Events

Chris Hanson-Ehlinger
Mon, Jun, 10, 2013

The inevitable CMS audit: two steps to get prepared now

Chris Hanson-Ehlinger
Mon, Jun, 10, 2013

CMS Part C Changes to Special Needs Plan for 2012 and 2013

Chris Hanson-Ehlinger
Fri, May, 31, 2013

How are exchanges handling pharmacy benefits?

Chris Hanson-Ehlinger
Thu, May, 23, 2013

Plan ahead: CMS issues new LTC reporting requirements

Chris Hanson-Ehlinger
Tue, May, 21, 2013

CMS changes Medication Therapy Management (MTM) reporting

Chris Hanson-Ehlinger
Fri, May, 10, 2013

Zero cost share for 2014 pharmacy preventive services

Chris Hanson-Ehlinger
Fri, May, 10, 2013

CMS shares important exchange implementation facts

Chris Hanson-Ehlinger
Wed, May, 08, 2013

Three considerations before you cover compounded medications

Chris Hanson-Ehlinger
Tue, Apr, 23, 2013

Four steps toward better specialty medication management

Chris Hanson-Ehlinger
Fri, Apr, 12, 2013

Shrinking rebates: how they affect plan sponsors

Chris Hanson-Ehlinger
Fri, Apr, 05, 2013

New CMS guidance works to minimize number of resubmissions

Chris Hanson-Ehlinger
Fri, Mar, 22, 2013

Newest changes to CMS data validation guidance and tech specs

Chris Hanson-Ehlinger
Fri, Mar, 08, 2013

Data validation cycle 2013 greatly impacted by recent CMS change

Chris Hanson-Ehlinger
Fri, Feb, 15, 2013
Article

Solve Business Problems with Effective and Comprehensive Pharmacy Solutions

Read Article
Privacy Policy